Howard Hughes Medical Institute investigators have been involved in many recent advances, from the discovery of genes related to cancer, heart disease, obesity, cystic fibrosis, muscular dystrophy and other diseases to new insights about how organisms develop, cells communicate and learning occurs.
UT Southwestern is honored to have Dr. Levine added to our team of HHMI investigators, said Dr. Kern Wildenthal, president of UT Southwestern. The selection process is exceptionally competitive and HHMI awardees rank among the most outstanding biomedical researchers in the world.
Since the early 1990s, HHMI has appointed 297 physician-scientists at 64 institutions nationwide.
As an investigator, Dr. Levine said part of her research will be directed toward confirming the role defective autophagy plays in patients with breast cancer, HIV infection and autoimmune diseases such as lupus in order to potentially develop therapies to correct these defects.
Dr. Levine earned her medical degree from Cornell University Medical College. She completed a postdoctoral fellowship in infectious diseases at Johns Hopkins Hospital and joined the UT Southwestern faculty in July 2004. A recipient of the American Cancer Society TIAA-CREF Award for Outstanding Achievements in Cancer Research, Dr. Levine was elected to membership in the American Society of Clinical Investigation in 2000 and the Association of American Physicians in 2006.
In addition to Dr. Levine, HHMI researchers at UT Southwestern include Dr. Zhijian James Chen, professor of microbiology; Dr. Johann Deisenhofer, professor of biochemistry; Dr. Nick V. Grishin, associate professor of biochemistry; Dr. Helen Hobbs, director of the Eugene McDermott Center
|Contact: Kristen Holland Shear|
UT Southwestern Medical Center